Fortis’s Agilus challenge deepens

Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.

9 October, 202410 min
0
Fortis’s Agilus challenge deepens

You may also like

Business
Story image

Devi Shetty’s contrarian bet in expanding to the United Kingdom

On the surface, Narayana Health’s latest acquisition holds promise. But a closer look suggests that the UK’s Practice Plus Group will need a bit of a turnaround before it can start yielding results.

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.

Business
Story image

How India’s retail shareholders are being left holding the can

Swiggy and Ola Electric’s plans to return to the public markets soon after big-bang IPOs leave investors with dilution, little prospect of returns and plenty of questions.